Koh-ichi Yuhki

1.3k total citations
17 papers, 1.0k citations indexed

About

Koh-ichi Yuhki is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Koh-ichi Yuhki has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 5 papers in Molecular Biology. Recurrent topics in Koh-ichi Yuhki's work include Inflammatory mediators and NSAID effects (11 papers), Nitric Oxide and Endothelin Effects (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Koh-ichi Yuhki is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Nitric Oxide and Endothelin Effects (5 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). Koh-ichi Yuhki collaborates with scholars based in Japan. Koh-ichi Yuhki's co-authors include Fumitaka Ushikubi, Shuh Narumiya, Takayuki Fujino, Osamu Takahata, Akiyoshi Hara, Takehiro Yamada, Takanobu Taniguchi, Chun-Yang Xiao, Kōji Takayama and Yuji Okada and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Koh-ichi Yuhki

17 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koh-ichi Yuhki Japan 14 360 303 294 256 186 17 1.0k
Rania Nasrallah Canada 17 230 0.6× 402 1.3× 194 0.7× 192 0.8× 165 0.9× 34 1.2k
Jessie N. Lindsley United States 19 191 0.5× 401 1.3× 138 0.5× 213 0.8× 200 1.1× 30 1.4k
Karen A. Munger United States 19 183 0.5× 364 1.2× 210 0.7× 201 0.8× 308 1.7× 41 1.2k
Francesca Seta United States 26 245 0.7× 548 1.8× 293 1.0× 497 1.9× 318 1.7× 48 1.8k
Ann Smart United States 15 354 1.0× 532 1.8× 269 0.9× 335 1.3× 309 1.7× 17 1.2k
Giulio A. Cinotti Italy 24 576 1.6× 431 1.4× 309 1.1× 367 1.4× 245 1.3× 70 2.0k
Youichi Akai Japan 6 533 1.5× 226 0.7× 309 1.1× 175 0.7× 133 0.7× 10 892
Laine J. Murphey United States 24 241 0.7× 325 1.1× 119 0.4× 494 1.9× 149 0.8× 38 1.8k
Scott Gleim United States 18 264 0.7× 357 1.2× 128 0.4× 172 0.7× 100 0.5× 29 873
Maurizio Degan Italy 20 184 0.5× 326 1.1× 185 0.6× 345 1.3× 248 1.3× 58 1.2k

Countries citing papers authored by Koh-ichi Yuhki

Since Specialization
Citations

This map shows the geographic impact of Koh-ichi Yuhki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koh-ichi Yuhki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koh-ichi Yuhki more than expected).

Fields of papers citing papers by Koh-ichi Yuhki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koh-ichi Yuhki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koh-ichi Yuhki. The network helps show where Koh-ichi Yuhki may publish in the future.

Co-authorship network of co-authors of Koh-ichi Yuhki

This figure shows the co-authorship network connecting the top 25 collaborators of Koh-ichi Yuhki. A scholar is included among the top collaborators of Koh-ichi Yuhki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koh-ichi Yuhki. Koh-ichi Yuhki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kashiwagi, Hitoshi, Koh-ichi Yuhki, Yoshitaka Imamichi, et al.. (2019). Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice. Thrombosis and Haemostasis. 119(8). 1311–1320. 9 indexed citations
2.
Imamichi, Yoshitaka, Koh-ichi Yuhki, Makoto Orisaka, et al.. (2016). 11-Ketotestosterone Is a Major Androgen Produced in Human Gonads. The Journal of Clinical Endocrinology & Metabolism. 101(10). 3582–3591. 75 indexed citations
3.
Andoh, Tsugunobu, Akito Yamamoto, Koh-ichi Yuhki, et al.. (2016). Thromboxane A2 is Involved in Itch-associated Responses in Mice with Atopic Dermatitis-like Skin Lesions. Acta Dermato Venereologica. 96(7). 899–904. 11 indexed citations
4.
Kashiwagi, Hitoshi, Koh-ichi Yuhki, Shima Kumei, et al.. (2015). The Novel Prostaglandin I2 Mimetic ONO-1301 Escapes Desensitization in an Antiplatelet Effect Due to Its Inhibitory Action on Thromboxane A2 Synthesis in Mice. Journal of Pharmacology and Experimental Therapeutics. 353(2). 269–278. 8 indexed citations
5.
Nakagawa, Naoki, Koh-ichi Yuhki, Takayuki Fujino, et al.. (2012). The intrinsic prostaglandin E2–EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney International. 82(2). 158–171. 67 indexed citations
6.
Yuhki, Koh-ichi, et al.. (2010). Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies. Pharmacology & Therapeutics. 129(2). 195–205. 73 indexed citations
7.
Yuhki, Koh-ichi, Hitoshi Kashiwagi, Fumiaki Kojima, Jun-ichi Kawabe, & Fumitaka Ushikubi. (2010). Roles of prostanoids in the pathogenesis of cardiovascular diseases.. PubMed. 29(2 Suppl). 19–27. 27 indexed citations
8.
Yuhki, Koh-ichi, Motoi Okada, Takaaki Sasaki, et al.. (2009). Prostaglandin I 2 Promotes Recruitment of Endothelial Progenitor Cells and Limits Vascular Remodeling. Arteriosclerosis Thrombosis and Vascular Biology. 30(3). 464–470. 53 indexed citations
9.
Yuhki, Koh-ichi, Fumitaka Ushikubi, Hiroaki Naraba, et al.. (2008). Prostaglandin I2 Plays a Key Role in Zymosan-Induced Mouse Pleurisy. Journal of Pharmacology and Experimental Therapeutics. 325(2). 601–609. 17 indexed citations
10.
Takayama, Kōji, Koh-ichi Yuhki, Kyoichi Ono, et al.. (2005). Thromboxane A2 and prostaglandin F2α mediate inflammatory tachycardia. Nature Medicine. 11(5). 562–566. 123 indexed citations
11.
Hara, Akiyoshi, Koh-ichi Yuhki, Takayuki Fujino, et al.. (2005). Augmented Cardiac Hypertrophy in Response to Pressure Overload in Mice Lacking the Prostaglandin I 2 Receptor. Circulation. 112(1). 84–92. 86 indexed citations
12.
Fujino, Takayuki, Naoki Nakagawa, Koh-ichi Yuhki, et al.. (2004). Decreased susceptibility to renovascular hypertension in mice lacking the prostaglandin I2 receptor IP. Journal of Clinical Investigation. 114(6). 805–812. 83 indexed citations
13.
Yuhki, Koh-ichi, Akinori Ueno, Hiroaki Naraba, et al.. (2004). Prostaglandin Receptors EP2, EP3, and IP Mediate Exudate Formation in Carrageenin-Induced Mouse Pleurisy. Journal of Pharmacology and Experimental Therapeutics. 311(3). 1218–1224. 32 indexed citations
14.
Xiao, Chun-Yang, Koh-ichi Yuhki, Akiyoshi Hara, et al.. (2004). Prostaglandin E 2 Protects the Heart From Ischemia-Reperfusion Injury via Its Receptor Subtype EP 4. Circulation. 109(20). 2462–2468. 146 indexed citations
15.
Yamada, Takehiro, Takayuki Fujino, Koh-ichi Yuhki, et al.. (2003). Thromboxane A 2 Regulates Vascular Tone via Its Inhibitory Effect on the Expression of Inducible Nitric Oxide Synthase. Circulation. 108(19). 2381–2386. 42 indexed citations
16.
Xiao, Chun-Yang, Akiyoshi Hara, Koh-ichi Yuhki, et al.. (2001). Roles of Prostaglandin I 2 and Thromboxane A 2 in Cardiac Ischemia-Reperfusion Injury. Circulation. 104(18). 2210–2215. 165 indexed citations
17.
Yuhki, Koh-ichi, Takashi Miyauchi, Yoshihiko Kakinuma, et al.. (2001). Endothelin-1 Production Is Enhanced by Rotenone, a Mitochondrial Complex I Inhibitor, in Cultured Rat Cardiomyocytes. Journal of Cardiovascular Pharmacology. 38(6). 850–858. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rania Nasrallah Breakdown of academic impact, for papers by Jessie N. Lindsley Breakdown of academic impact, for papers by Karen A. Munger Breakdown of academic impact, for papers by Francesca Seta Breakdown of academic impact, for papers by Ann Smart Breakdown of academic impact, for papers by Giulio A. Cinotti Breakdown of academic impact, for papers by Youichi Akai Breakdown of academic impact, for papers by Laine J. Murphey Breakdown of academic impact, for papers by Scott Gleim Breakdown of academic impact, for papers by Maurizio Degan
Rankless by CCL
2026